Table 4.

Hepatitis C virus serofrequency in high risk population groups

S. #	Year	Place	Method	Sample size	Seroprevalence (%)	Ref.
Pregnant women
1	2009	Hazara	ELISA1	500	8.6	[104]
2	2009	Swat	ICT6	5607	2.6	[105]
3	2009	Karachi	EIA2	5902	1.8	[106]
4	2010	Multan	ICT6	500	7.0	[107]
5	2011	Karachi	ELISA3	18000	5.79	[102]
6	2013	Hyderabad	ELISA2	3078	4.7	[103]
Multi-transfused population (including pediatric population)
7	2009	Islamabad	ELISA6	103	36.0	[108]
8	2010	Lahore	Questionnaire	408	1.5	[110]
9	2011	KPK	ICT4	40	15.0	[111]
10	2011	Karachi	ELISA3	173	51.4	[86]
11	2012	Karachi	ELISA5	160	13.0	[83]
12	2014	Rawalpindi	ELISA6	95	49.5	[109]
Intravenous drug users
13	2011	KPK	ICT4	42	14.28	[111]
14	2011	KPK	ICT4			[113]
		Peshawar		100	35.0
		Kohat		60	25.0
		Mardan		40	32.5

¹Ortho Clinical Diagnostics;

²Abbott Diagnostics;

³DiaSorin;

⁴Acon Laboratories, CA, United States;

⁵General Biologicals Corporation;

⁶Manufacturer not mentioned in cited reference. KPK: Khyber Pakhtunkhwa; ELISA: Enzyme linked immunosorbent assay; EIA: Enzyme immunoassay; ICT: Immunochromatographic test.